Literature DB >> 25149084

GLP-1 receptor agonist increases the expression of CTRP3, a novel adipokine, in 3T3-L1 adipocytes through PKA signal pathway.

X Li1, L Jiang2, M Yang3, Y Wu3, S Sun3, J Sun3.   

Abstract

OBJECTIVE: To investigate the effects of Exendin-4 (Ex-4), a glucagon-like peptide-1 (GLP-1) receptor agonist, on the expression of C1q/TNF-related protein-3 (CTRP3), a novel adipokine, in 3T3-L1 adipocytes. The role of protein kinase A (PKA) signal pathway in the effects was also investigated.
METHODS: The mRNA and protein expressions of CTRP3 in 3T3-L1 adiocytes were detected by real-time polymerase chain reaction and western blot, respectively. Exendin-fragment 9-39 (Ex-9), a specific GLP-1 receptor antagonist, and H89, a selective antagonist of PKA, were used to confirm the signal pathway of Ex-4 on CTRP3.
RESULTS: 2.5 or 5.0 nmol/l Ex-4 treatment for 8 h increased the expressions of CTRP3 mRNA and protein as well as PKA protein in 3T3-L1 adipocytes significantly, while Ex-9 or H89 blocked the up-regulation of CTRP3 expression induced by Ex-4 completely.
CONCLUSION: GLP-1 receptor agonist increases the expression of CTRP3 mRNA and protein in 3T3-L1 adipocytes via PKA signal pathway.

Entities:  

Keywords:  C1q/TNF-related protein-3 (CTRP3); Glucagon-like peptide-1 (GLP-1); Protein kinase A (PKA)

Mesh:

Substances:

Year:  2014        PMID: 25149084     DOI: 10.1007/s40618-014-0156-8

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

Review 1.  Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases.

Authors:  Christian Hölscher
Journal:  J Endocrinol       Date:  2014-03-07       Impact factor: 4.286

Review 2.  Gastrointestinal regulatory peptides and their effects on fat tissue.

Authors:  Ishita D Majumdar; Horst C Weber
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-02       Impact factor: 3.243

Review 3.  Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity.

Authors:  Martin Lorenz; Andreas Evers; Michael Wagner
Journal:  Bioorg Med Chem Lett       Date:  2013-05-16       Impact factor: 2.823

4.  Effects of the new adiponectin paralogous protein CTRP-3 and of LPS on cytokine release from monocytes of patients with type 2 diabetes mellitus.

Authors:  Andrea Kopp; Margarita Bala; Johanna Weigert; Christa Büchler; Markus Neumeier; Charalampos Aslanidis; Jürgen Schölmerich; Andreas Schäffler
Journal:  Cytokine       Date:  2009-12-01       Impact factor: 3.861

5.  Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression.

Authors:  Le Thi Kim Chung; Toshio Hosaka; Masaki Yoshida; Nagakatsu Harada; Hiroshi Sakaue; Tohru Sakai; Yutaka Nakaya
Journal:  Biochem Biophys Res Commun       Date:  2009-10-20       Impact factor: 3.575

6.  The novel adipokine C1q/TNF-related protein-3 is expressed in human adipocytes and regulated by metabolic and infection-related parameters.

Authors:  A Schmid; A Kopp; F Hanses; M Bala; M Müller; A Schäffler
Journal:  Exp Clin Endocrinol Diabetes       Date:  2012-11-22       Impact factor: 2.949

Review 7.  GLP-1 effects on islets: hormonal, neuronal, or paracrine?

Authors:  Marc Y Donath; Rémy Burcelin
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

Review 8.  Glucose-dependent insulinotropic polypeptide signaling in pancreatic β-cells and adipocytes.

Authors:  Christopher Hs McIntosh; Scott Widenmaier; Su-Jin Kim
Journal:  J Diabetes Investig       Date:  2012-03-28       Impact factor: 4.232

9.  Effects of a combined aerobic and resistance exercise program on C1q/TNF-related protein-3 (CTRP-3) and CTRP-5 levels.

Authors:  Hae Yoon Choi; Ji Woo Park; Namseok Lee; Soon Young Hwang; Geum Ju Cho; Ho Cheol Hong; Hye Jin Yoo; Taek Geun Hwang; Seon Mi Kim; Sei Hyun Baik; Kyong Soo Park; Byung-Soo Youn; Kyung Mook Choi
Journal:  Diabetes Care       Date:  2013-06-18       Impact factor: 19.112

10.  GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats.

Authors:  Kirk M Habegger; Kristy M Heppner; Sarah E Amburgy; Nickki Ottaway; Jenna Holland; Christine Raver; Erin Bartley; Timo D Müller; Paul T Pfluger; Jose Berger; Mouhamadoul Toure; Stephen C Benoit; Richard D Dimarchi; Diego Perez-Tilve; David A D'Alessio; Randy J Seeley; Matthias H Tschöp
Journal:  Diabetes       Date:  2013-11-01       Impact factor: 9.461

View more
  7 in total

Review 1.  C1q/TNF-Related Protein 3 (CTRP3) Function and Regulation.

Authors:  Ying Li; Gary L Wright; Jonathan M Peterson
Journal:  Compr Physiol       Date:  2017-06-18       Impact factor: 9.090

2.  Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus.

Authors:  Reza Fadaei; Nariman Moradi; Mehdi Baratchian; Hassan Aghajani; Mojtaba Malek; Ali Akbar Fazaeli; Soudabeh Fallah
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

Review 3.  Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function.

Authors:  Jordan Rowlands; Julian Heng; Philip Newsholme; Rodrigo Carlessi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-23       Impact factor: 5.555

4.  Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function.

Authors:  Nariman Moradi; Reza Fadaei; Mohammad Ebrahim Khamseh; Ali Nobakht; Mohammad Jafar Rezaei; Fereshteh Aliakbary; Akram Vatannejad; Jalil Hosseini
Journal:  PLoS One       Date:  2019-04-22       Impact factor: 3.240

Review 5.  Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies.

Authors:  Amrita Banerjee; Jagdish Singh
Journal:  Bioeng Transl Med       Date:  2019-12-13

Review 6.  New Insights Into Implications of CTRP3 in Obesity, Metabolic Dysfunction, and Cardiovascular Diseases: Potential of Therapeutic Interventions.

Authors:  Bei Guo; Tongtian Zhuang; Feng Xu; Xiao Lin; Fuxingzi Li; Su-Kang Shan; Feng Wu; Jia-Yu Zhong; Yi Wang; Ming-Hui Zheng; Qiu-Shuang Xu; Ullah Muhammad Hasnain Ehsan; Ling-Qing Yuan
Journal:  Front Physiol       Date:  2020-12-03       Impact factor: 4.566

7.  Decreased Epicardial CTRP3 mRNA Levels in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease Undergoing Elective Cardiac Surgery: A Possible Association with Coronary Atherosclerosis.

Authors:  Zdenek Matloch; Milos Mraz; Barbora Judita Kasperova; Helena Kratochvilova; Petr Svoboda; Iveta Pleyerova; Katerina Reznickova; Sarah Norman; Daniel Hlavacek; Jakub Mahrik; Peter Ivak; Zdenka Lacinova; Ivan Netuka; Martin Haluzik
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.